Skip to main content

12 Result(s)

within John R Ingram Remove this filter

and

  1. No Access

    Article

    Methodological innovations and stakeholder involvement in core outcome sets for skin diseases: a survey of the C3 working groups

    Areeba Ahmed, Eric Koza, Victoria Shi, Melissa Ma… in Archives of Dermatological Research (2024)

  2. No Access

    Article

    Clinical relevance and uptake of core outcome sets in dermatology

    Areeba Ahmed, Eric Koza, Victoria Shi, Melissa Ma… in Archives of Dermatological Research (2024)

  3. Article

    Open Access

    Burden of Hidradenitis Suppurativa: A Systematic Literature Review of Patient Reported Outcomes

    Hidradenitis suppurativa (HS) has a profound negative impact on patients’ health-related quality of life (HRQoL). Here we summarize the evidence on HRQoL and Patient Reported Outcomes (PROs) in patients with H...

    Alexa B. Kimball, Joslyn Kirby, John R. Ingram, Tanja Tran… in Dermatology and Therapy (2024)

    Download PDF (1071 KB) View Article

  4. Article

    Open Access

    Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe

    Hidradenitis suppurativa is a chronic inflammatory skin disease that can lead to a substantial reduction in quality of life. Recent studies revealed high levels of unmet care needs of patients with hidradeniti...

    Damon Willems, Eva-Lotta Hinzpeter… in The Patient - Patient-Centered Outcomes Re… (2023)

    Download PDF (1927 KB) View Article

  5. No Access

    Article

    Adalimumab for Treating Moderate-to-Severe Hidradenitis Suppurativa: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

    As part of its single technology appraisal (STA) process, the UK National Institute for Health and Care Excellence (NICE) invited the manufacturer of adalimumab (AbbVie) to submit evidence on the clinical effe...

    Paul Tappenden, Christopher Carroll, John W. Stevens, Andrew Rawdin… in PharmacoEconomics (2017)

  6. Article

    Open Access

    Postprandial effects of a polyphenolic grape extract (PGE) supplement on appetite and food intake: a randomised dose-comparison trial

    There is recent evidence that glucose delivered to the distal small intestine (SI) may stimulate the ileal brake and inhibit appetite. High polyphenolic grape extract (PGE) has been shown to inhibit α-amylase ...

    Hyun-San Shin, Sophie Kindleysides, Wilson Yip, Stephanie C. Budgett… in Nutrition Journal (2015)

    Download PDF (724 KB) View Article

  7. Article

    Open Access

    Validation of the global resource of eczema trials (GREAT database)

    Eczema (syn. Atopic Eczema or Atopic Dermatitis) is a chronic, relapsing, itchy skin condition which probably results from a combination of genetic and environmental factors. The Global Resource of EczemA Tria...

    Helen Nankervis, Alison Devine, Hywel C Williams, John R Ingram… in BMC Dermatology (2015)

    Download PDF (391 KB) View Article

  8. No Access

    Article

    Alitretinoina nell’eczema cronico grave alle mani. Valutazione di tecnologia singola presso il NICE

    The National Institute for Health and Clinical Excellence (NICE) invited the manufacturer of alitretinoin (Basilea Pharmaceuticals Ltd, Basel, Switzerland) to submit evidence for the clinical and cost effectiv...

    Mr Mark Rodgers, Susan Griffin, Mike Paulden… in PharmacoEconomics Italian Research Articles (2011)

  9. No Access

    Article

    Ultradian rhythmicity and induced changes in salivary testosterone

    Testosterone and cortisol respond to exercise stimuli and modulate adaptation. Episodic basal secretion of these hormones may modify the responsiveness of these hormones. We sought to identify episodic steroid...

    C. Martyn Beaven, John R. Ingram… in European Journal of Applied Physiology (2010)

  10. Article

    Open Access

    Problems in the reporting of acne clinical trials: a spot check from the 2009 Annual Evidence Update on Acne Vulgaris

    In the course of producing the 2009 NHS Evidence - skin disorders Annual Evidence Update on Acne Vulgaris, 25 randomised controlled trials were examined. From these, at least 12 potentially serious problems of...

    John R Ingram, Douglas JC Grindlay, Hywel C Williams in Trials (2010)

    Download PDF (628 KB) View Article

  11. No Access

    Article

    Alitretinoin for Severe Chronic Hand Eczema

    The National Institute for Health and Clinical Excellence (NICE) invited the manufacturer of alitretinoin (Basilea Pharmaceuticals Ltd, Basel, Switzerland) to submit evidence for the clinical and cost effectiv...

    Mr Mark Rodgers, Susan Griffin, Mike Paulden, Russell Slack… in PharmacoEconomics (2010)

  12. No Access

    Article

    Mechanisms of Disease: nicotine—a review of its actions in the context of gastrointestinal disease

    Smoking can have a detrimental and beneficial effect on gastrointestinal disease—it has such a 'polarizing effect' in patients with Crohn's disease and ulcerative colitis. Studies in tobacco smokers have made ...

    Gareth AO Thomas, John Rhodes, John R Ingram in Nature Clinical Practice Gastroenterology … (2005)